Biopharma Leaders Unite To Stand With Science LEARN MORE Pfizer & BioNTech to Supply Singapore with Vaccine Candidate to Combat COVID-19 LEARN MORE PFIZER INVESTS $120MIL IN BIOTECH INNOVATION LEARN MORE Pfizer Confirms U.S. Patent Term Extension for IBRANCE® (palbociclib) Until March 2027 LEARN MORE AGREEMENT REACHED WITH COVAX FOR ADVANCE PURCHASE OF COVID-19 VACCINE LEARN MORE RECENT PRESS RELEASES 24/06/2020 - Pfizer and Wellcome Launch Surveillance Program to Combat Growing Threat of Antimicrobial Resistance in Sub-Saharan Africa 22/06/2020 - European Medicines Agency Validates Application for BAVENCIO® (avelumab) for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma 22/06/2020 - Pfizer Announces Start of Four Phase 3 Clinical Trials for Investigational Vaccines 18/06/2020 - Pfizer and Sangamo Announce Updated Phase 1/2 Results Showing Sustained Factor VIII Activity Levels and No Bleeding Events or Factor Usage in 3e13 vg/kg Cohort Following giroctocogene fitelparvovec (SB-525) Gene Therapy 18/06/2020 - Upjohn Announces Pricing of Senior Notes in Connection with the Proposed Combination of Mylan and Upjohn 16/06/2020 - Pfizer Invites Public to View and Listen to Webcast of July 28 Conference Call with Analysts 12/06/2020 - Pfizer Invites Public to View and Listen to Webcast of June 18 Conference Call with Analysts to Review Data Presentations at Scientific Conferences during the Week of June 15th 11/06/2020 - FDA Approves Pfizer’s Oncology Supportive Care Biosimilar, NYVEPRIA™ (pegfilgrastim-apgf) 10/06/2020 - Pfizer Announces Positive Top-Line Results from JADE TEEN Trial of Abrocitinib in Adolescents with Moderate-to-Severe Atopic Dermatitis 03/06/2020 - Complete Results from Second Pivotal Monotherapy Study of Abrocitinib Published in JAMA Dermatology 02/06/2020 - Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference 02/06/2020 - Pfizer Establishes New Program to Support Continued Biotechnology Innovation 29/05/2020 - Pfizer Provides Update on Phase 3 PALLAS Trial of IBRANCE® (palbociclib) Plus Endocrine Therapy in HR+, HER2- Early Breast Cancer 29/05/2020 - Final PROSPER Results Show XTANDI® (enzalutamide) Significantly Extends Overall Survival in Men with Non-Metastatic Castration-Resistant Prostate Cancer 22/05/2020 - Pfizer Inc. Recommends Rejection of Unsolicited Note Tender Offer by Huguenot Bond Liquidity, LLC Pagination First page « First Previous page ‹ Previous Page 4 Page 5 Page 6 Page 7 Current page 8 Page 9 Page 10 Page 11 Page 12 Next page Next › Last page Last »
